omegaxanthin
For heart and brain health
A combination of concentrated omega-3 fish oil (500mg EPA and 250mg DHA) and Astaxanthin for numerous health benefits
Benefits:
-
Maintain healthy heart and circulatory functions
-
Improve blood lipid profile
-
Better brain and cognitive functions
-
Anti-inflammation
-
Natural anti-oxidant - protects body cells from free radicals
Uniqueness:
-
High concentration & high purity
-
Free of pollutants and better protected from oxidation
-
Scientifically studied for safety and efficacy
omega-3 FISH OIL
SEE THE EFFECTS ON YOUR CARDIAC HEALTH WITHIN WEEKS
KEY FEATURES:
-
Omega-3 fish oil exist in highly absorbable triglyceride form
-
Source is from world-class Norwegian Partners, BASF
THE GAINS IN LINES OF VISION DURING EYE ASSESSMENT FOR AMD PATIENTS ON OMEGA-3 SUPPLEMENTATION
RECOMMENDED NUTRIENT INTAKE (RNI) FOR EPA AND DHA
ASTAXANTHIN
Omegaxanthin also contains additional booster power of Astaxanthin, the "King of Antioxidants" sourced from Japanese global leading company, AstaReal
product nutritional information
Packaging size: 60 softgel capsules
Each 1450mg Softgel Capsule Contains:
Fish oil.................................................................1000mg
Equiv. to Eicosapentaenoic acid: 500 mg
Equiv. to Docosahexaenoic acid: 200 mg
Haematococcus Pluvialis Extract.......................20mg
Equiv. to 2mg of Astaxanthin
Direction to use:
Adult: Take 1 softgel capsule once daily, after meal or as directed by pharmacist / doctor
Indication:
Used as health supplement
Source of capsule: Bovine
This product contains substance derived from seafood
Reference:
-
Omega-3 Fatty Acids: Fact Sheet for Health Professionals (National Institute of Health, Office of Dietary Supplements)
-
Global Recommendations for EPA and DHA intake (Rev 16 April 2014)
-
Ambati RR, Phang SM, Ravi S, Ashwathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications - a review. Mar Drugs. 2014 Jan 7;12(1):128-52
-
Georgiou T, Neokleous A, Nikolaou D, and Sears B. Pilot study for treating dry age-related macular degenaration (AMD) with high-dose omega-3 fatty acids. PharmaNutrition 2:8-11 (2014)
-
Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1679-85
-
Lee JH, Prasad A, Jarreau TK, O'Keefe JH, Milani R et al., (2011) Omega-3 Fatty Acids and Cardiovascular Disease. JMarine Sci Res Development S1:001
-
Lu et al., (2010) Brain Res Nov 11;1360:40-8.